Year |
Citation |
Score |
2024 |
DeSouza NR, Nielsen KJ, Jarboe T, Carnazza M, Quaranto D, Kopec K, Suriano R, Islam HK, Tiwari RK, Geliebter J. Dysregulated Expression Patterns of Circular RNAs in Cancer: Uncovering Molecular Mechanisms and Biomarker Potential. Biomolecules. 14. PMID 38672402 DOI: 10.3390/biom14040384 |
0.491 |
|
2018 |
Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomarkers : Section a of Disease Markers. PMID 30614796 DOI: 10.3233/Cbm-181758 |
0.551 |
|
2018 |
Maniyar R, Chakraborty S, Suriano R. Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer. Journal of Cancer. 9: 3874-3885. PMID 30410590 DOI: 10.7150/Jca.25581 |
0.431 |
|
2016 |
Maniyar RR, Bednarczyk RB, Rahoma GMB, Tuli N, Mittelman A, Tiwari RK, Suriano R. Abstract 3365: Provasculogenic effects of alcohol and estrogen: implications for breast cancer development Cancer Research. 76: 3365-3365. DOI: 10.1158/1538-7445.Am2016-3365 |
0.575 |
|
2016 |
Maniyar RR, Tuli N, Suriano R, Geliebter J, Wallack M, Tiwari RK. Abstract 2365: Checkpoint inhibitors and a multivalent melanoma vaccine as a novel combinatorial therapy Cancer Research. 76: 2365-2365. DOI: 10.1158/1538-7445.Am2016-2365 |
0.632 |
|
2015 |
Hanly EK, Tuli NY, Bednarczyk RB, Suriano R, Geliebter J, Moscatello AL, Darzynkiewicz Z, Tiwari RK. Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget. PMID 26735176 DOI: 10.18632/Oncotarget.6779 |
0.588 |
|
2015 |
George AL, Suriano R, Rajoria S, Osso MC, Tuli N, Hanly E, Geliebter J, Arnold AN, Wallack M, Tiwari RK. PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. Journal of Cancer. 6: 1320-1330. PMID 26640592 DOI: 10.7150/Jca.11126 |
0.56 |
|
2015 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack M. Abstract A30: Small molecule kinase inhibitor mediated modulation of immunotherapy in melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A30 |
0.608 |
|
2015 |
Suriano R, Tuli NY, Geliebter J, Tiwari RK, Wallack M. Abstract 3540: Novel targeted combinational therapies for melanoma Cancer Research. 75: 3540-3540. DOI: 10.1158/1538-7445.Am2015-3540 |
0.531 |
|
2014 |
Hanly EK, Rajoria S, Darzynkiewicz Z, Zhao H, Suriano R, Tuli N, George AL, Bednarczyk R, Shin EJ, Geliebter J, Tiwari RK. Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. Bmc Research Notes. 7: 187. PMID 24673746 DOI: 10.1186/1756-0500-7-187 |
0.653 |
|
2014 |
Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, Suriano R, Carpi A, Tiwari RK. Interlinking of hypoxia and estrogen in thyroid cancer progression. Current Medicinal Chemistry. 21: 1351-60. PMID 24304276 DOI: 10.2174/0929867321666131201142434 |
0.683 |
|
2014 |
Tiwari RK, Suriano R, Banerjee D, Konopa J, Geliebter J, Mittelman A. Capridine-β, a new class of chemotherapeutic agents for prostate cancer. Journal of Clinical Oncology. 32: e16062-e16062. DOI: 10.1200/Jco.2014.32.15_Suppl.E16062 |
0.574 |
|
2014 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack MK. Abstract 641: Targeted inhibition of BRAF signaling in melanoma enhances the activity of a multivalent immunotherapeutic vaccine Cancer Research. 74: 641-641. DOI: 10.1158/1538-7445.Am2014-641 |
0.621 |
|
2014 |
Kitadai R, Bednarczyk R, Tuli N, Hanly E, Benrahoma G, Suriano R, Mittelman A, Tiwari RK. Abstract 3889: Modulation of breast cancer stem cell marker CD44 by all-trans-retinoic acid (ATRA) Cancer Research. 74: 3889-3889. DOI: 10.1158/1538-7445.Am2014-3889 |
0.616 |
|
2014 |
Hanly EK, Tuli NY, Suriano R, Bednarczyk R, Darzynkiewicz Z, Moscatello AL, Shin EJ, Geliebter J, Tiwari RK. Abstract 3709: Resistance mechanisms to targeted molecular therapy in thyroid cancer Cancer Research. 74: 3709-3709. DOI: 10.1158/1538-7445.Am2014-3709 |
0.674 |
|
2014 |
Bednarczyk R, Tuli N, Benrahoma G, Kitadai R, Suriano R, Mittelman A, Tiwari RK. Abstract 1171: Proinflammatory chemokine interleukin-8 in the tumor microenvironment modulates breast cancer phenotype Cancer Research. 74: 1171-1171. DOI: 10.1158/1538-7445.Am2014-1171 |
0.647 |
|
2014 |
Tuli NY, Cabin J, Suriano R, Bednarczyk R, Hanly E, Geliebter J, Shin E, Tiwari RK. Abstract 1107: Tumor microenvironment based modulation of thyroid cancer phenotype Cancer Research. 74: 1107-1107. DOI: 10.1158/1538-7445.Am2014-1107 |
0.684 |
|
2013 |
Suriano R, Rajoria S, George AL, Geliebter J, Tiwari RK, Wallack M. Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma. Molecular and Clinical Oncology. 1: 466-472. PMID 24649193 DOI: 10.3892/Mco.2013.97 |
0.525 |
|
2013 |
Suriano R, Rajoria S, L George A, Geliebter J, Wallack M, Tiwari RK. Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines. Journal of Cancer. 4: 371-82. PMID 23833682 DOI: 10.7150/Jca.6625 |
0.614 |
|
2013 |
Suriano R, Rajoria S, George AL, Geliebter J, Wallack M, Tiwari RK. Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines Journal of Cancer. 4: 371-382. DOI: 10.7150/jca.6625 |
0.526 |
|
2013 |
Rajoria S, Hanly E, George A, Suriano R, Geliebter J, Saman M, Schantz S, Tiwari RK. Abstract 96: Estrogen modulates cellular and molecular markers of hypoxic tumor microenvironment in thyroid cancer. Cancer Research. 73: 96-96. DOI: 10.1158/1538-7445.Am2013-96 |
0.694 |
|
2013 |
Suriano R, George AL, Rajoria S, Geliebter J, Tiwari RK, Wallack M. Abstract 2829: Patient-derived primary melanoma cells that differentially express melano-specific antigens as a model for vaccines. Cancer Research. 73: 2829-2829. DOI: 10.1158/1538-7445.Am2013-2829 |
0.628 |
|
2013 |
George AL, Bednarczyk R, Rajoria S, Hanly E, Suriano R, Mittelman A, Tiwari RK. Abstract 1432: CXCL8 is a secretory inflammatory stimulus of the activated TME that modulates breast cancer phenotype. Cancer Research. 73: 1432-1432. DOI: 10.1158/1538-7445.Am2013-1432 |
0.64 |
|
2013 |
Hanly EK, Rajoria S, George AL, Suriano R, Geliebter J, Pantelides H, Shin EJ, Tiwari RK. Abstract 1048: Targeted BRAF therapy attenuates the promotional activity of estrogen in thyroid cancer. Cancer Research. 73: 1048-1048. DOI: 10.1158/1538-7445.Am2013-1048 |
0.668 |
|
2012 |
George AL, Rajoria S, Suriano R, Mittleman A, Tiwari RK. Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Molecular Cancer. 11: 80. PMID 23088607 DOI: 10.1186/1476-4598-11-80 |
0.6 |
|
2012 |
Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK. Molecular target based combinational therapeutic approaches in thyroid cancer. Journal of Translational Medicine. 10: 81. PMID 22548798 DOI: 10.1186/1479-5876-10-81 |
0.665 |
|
2012 |
Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. Plos One. 7: e30839. PMID 22363498 DOI: 10.1371/Journal.Pone.0030839 |
0.543 |
|
2012 |
Rajoria S, Suriano R, George AL, Shanmugam A, Jussim C, Shin EJ, Moscatello AL, Geliebter J, Carpi A, Tiwari RK. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 66: 151-8. PMID 22285105 DOI: 10.1016/J.Biopha.2011.11.010 |
0.627 |
|
2012 |
Shanmugam A, Rajoria S, George AL, Jussim C, Suriano R, Konopa J, Mittelman A, Tiwari RK. Abstract 3803: Anti-cancer activity of Capridine, a novel nitroacridine chemotherapeutic, in glioblastoma Cancer Research. 72: 3803-3803. DOI: 10.1158/1538-7445.Am2012-3803 |
0.664 |
|
2012 |
Jussim C, George AL, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK. Abstract 304: Proinflammatory secretory chemokine CXCL8 regulates intercellular cross-talk in the breast cancer tumor microenvironment Cancer Research. 72: 304-304. DOI: 10.1158/1538-7445.Am2012-304 |
0.659 |
|
2012 |
Suriano R, Rajoria S, George A, Jussim C, Shanmugam A, Geliebter J, Tiwari RK, Wallack MK. Abstract 1569: Multivalent melanoma vaccine using primary human melanoma cells and a vaccinia virus based antigen retrieval system Cancer Research. 72: 1569-1569. DOI: 10.1158/1538-7445.Am2012-1569 |
0.635 |
|
2012 |
Rajoria S, George A, Suriano R, Shin EJ, Geliebter J, Tiwari RK. Abstract 1520: Estrogen modulates angiogenic factors of thyroid tumor microenvironment Cancer Research. 72: 1520-1520. DOI: 10.1158/1538-7445.Am2012-1520 |
0.693 |
|
2012 |
George AL, Rajoria S, Suriano R, Mittelman A, Tiwari RK. Abstract 1494: Intrinsic and extrinsic TME factors modulate breast cancer progression Cancer Research. 72: 1494-1494. DOI: 10.1158/1538-7445.Am2012-1494 |
0.596 |
|
2011 |
Rajoria S, Suriano R, Wilson YL, George AL, Geliebter J, Schantz SP, Tiwari RK. Estradiol-mediated tumor neo-vascularization. Oncology Letters. 2: 453-457. PMID 22866102 DOI: 10.3892/Ol.2011.283 |
0.602 |
|
2011 |
Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, Prakash PB, Tiwari R, Schantz S. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Archives of Otolaryngology--Head & Neck Surgery. 137: 1146-53. PMID 22106242 DOI: 10.1001/Archoto.2011.194 |
0.634 |
|
2011 |
George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK. Endothelial progenitor cell biology in disease and tissue regeneration. Journal of Hematology & Oncology. 4: 24. PMID 21609465 DOI: 10.1186/1756-8722-4-24 |
0.613 |
|
2011 |
Shanmugam A, Suriano R, Chaudhuri D, Rajoria S, George A, Mittelman A, Tiwari RK. Identification of PSA peptide mimotopes using phage display peptide library. Peptides. 32: 1097-102. PMID 21539876 DOI: 10.1016/J.Peptides.2011.04.018 |
0.695 |
|
2011 |
Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. Plos One. 6: e15879. PMID 21267453 DOI: 10.1371/Journal.Pone.0015879 |
0.657 |
|
2011 |
Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK. 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid : Official Journal of the American Thyroid Association. 21: 299-304. PMID 21254914 DOI: 10.1089/Thy.2010.0245 |
0.623 |
|
2011 |
Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncology Reports. 25: 491-7. PMID 21152869 DOI: 10.3892/Or.2010.1076 |
0.66 |
|
2011 |
Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, Rajoria S, George AL, Mittelman A, Tiwari RK. Identification of peptide mimotopes of gp96 using single-chain antibody library. Cell Stress & Chaperones. 16: 225-34. PMID 20953748 DOI: 10.1007/S12192-010-0234-6 |
0.692 |
|
2011 |
Shanmugam A, Rajoria S, George A, Mittelman A, Tiwari RK, Suriano R. Abstract 5396: LPS mimotopes: A novel class of TLR4 agonist Cancer Research. 71: 5396-5396. DOI: 10.1158/1538-7445.Am2011-5396 |
0.495 |
|
2011 |
Singh A, Shanmugam A, Rajoria S, George A, Suriano R. Abstract 4558: Synergistic effect of alcohol and estradiol in breast cancer Cancer Research. 71: 4558-4558. DOI: 10.1158/1538-7445.Am2011-4558 |
0.4 |
|
2011 |
George AL, Rajoria S, Shanmugam A, Prakash PB, Suriano R, Tiwari RK. Abstract 1516: Estrogen regulated TME factors are novel modulators of neovasculogenesis and EMT in breast cancer Cancer Research. 71: 1516-1516. DOI: 10.1158/1538-7445.Am2011-1516 |
0.647 |
|
2011 |
Rajoria S, George A, Shanmugam A, Kamat A, Schantz SP, Geliebter J, Suriano R, Tiwari RK. Abstract 1320: Estrogen as a modulator of thyroid proliferative disease: Implications for disease etiology and therapy Cancer Research. 71: 1320-1320. DOI: 10.1158/1538-7445.Am2011-1320 |
0.559 |
|
2010 |
Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid : Official Journal of the American Thyroid Association. 20: 33-41. PMID 20067378 DOI: 10.1089/Thy.2009.0296 |
0.653 |
|
2010 |
Rajoria S, George A, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK, Suriano R. Abstract 5683: The dietary anti-estrogenic agent 3,3′-diindolylmethane inhibits metastatic propensity in thyroid cancer cells Cancer Research. 70: 5683-5683. DOI: 10.1158/1538-7445.Am10-5683 |
0.686 |
|
2010 |
Suriano R, Shanmugam A, Rajoria S, George A, Mittelman A, Tiwari RK. Abstract 5628: Synthetic peptide mimics of LPS: Potential role as novel adjuvants Cancer Research. 70: 5628-5628. DOI: 10.1158/1538-7445.Am10-5628 |
0.543 |
|
2010 |
Rajoria S, Suriano R, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK. Abstract 420: Metastatic and neo-vasculature determinants as prognostic markers of thyroid cancer Cancer Research. 70: 420-420. DOI: 10.1158/1538-7445.Am10-420 |
0.681 |
|
2010 |
Megwalu U, Suriano R, Shanmugam A, Schantz S, Tiwari R. The effect of DIM on Neovascularization in Thyroid Disease Otolaryngology–Head and Neck Surgery. 143: P74-P74. DOI: 10.1016/J.Otohns.2010.06.104 |
0.558 |
|
2009 |
Suriano R, Ghosh SK, Chaudhuri D, Mittelman A, Banerjee A, Tiwari RK. Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions. Glycobiology. 19: 1427-35. PMID 19578160 DOI: 10.1093/Glycob/Cwp096 |
0.719 |
|
2009 |
Chaudhuri D, Suriano R, Mittelman A, Tiwari RK. Targeting the immune system in cancer. Current Pharmaceutical Biotechnology. 10: 166-84. PMID 19199949 DOI: 10.2174/138920109787315114 |
0.729 |
|
2009 |
Wilson Y, Suriano R, Rajoria S, Tiwari R, Schantz S. Role of Estrogen in Thyroid Tumor Neo-Vascularization Otolaryngology–Head and Neck Surgery. 141: P57-P58. DOI: 10.1016/J.Otohns.2009.06.172 |
0.594 |
|
2008 |
Suriano R, Chaudhuri D, Johnson RS, Lambers E, Ashok BT, Kishore R, Tiwari RK. 17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Research. 68: 6038-42. PMID 18676823 DOI: 10.1158/0008-5472.Can-08-1009 |
0.71 |
|
2006 |
Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. Journal of Proteome Research. 5: 856-61. PMID 16602693 DOI: 10.1021/pr050349r |
0.523 |
|
2005 |
Suriano R, Ghosh SK, Ashok BT, Mittelman A, Chen Y, Banerjee A, Tiwari RK. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention. Cancer Research. 65: 6466-75. PMID 16024652 DOI: 10.1158/0008-5472.Can-04-4639 |
0.61 |
|
Show low-probability matches. |